SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-17-006506
Filing Date
2017-04-13
Accepted
2017-04-13 16:15:39
Documents
3
Effectiveness Date
2017-04-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A omed-defa14a_20160622.htm DEFA14A 29410
2 GRAPHIC g2017033018141005252866.jpg GRAPHIC 95134
3 GRAPHIC g2017033018141008152867.jpg GRAPHIC 93775
  Complete submission text file 0001564590-17-006506.txt   290862
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35993 | Film No.: 17760812
SIC: 2834 Pharmaceutical Preparations